Joel Schlessinger

2.1k citations
54 papers · 1.4k · 1 hit paper · h-index 22

Impact in

  • Dermatology top 0.2%
    • Hidradenitis Suppurativa and Treatments
    • Facial Rejuvenation and Surgery Techniques
    • Dermatologic Treatments and Research
    • Dermatology and Skin Diseases
    • Acne and Rosacea Treatments and Effects
  • Neurology top 5%
    • Botulinum Toxin and Related Neurological Disorders

Papers in

    • Dermatologic Treatments and Research 14
    • Dermatology and Skin Diseases 9
    • Acne and Rosacea Treatments and Effects 8
    • Facial Rejuvenation and Surgery Techniques 6
    • Botulinum Toxin and Related Neurological Disorders 15

Joel Schlessinger

49 papers receiving 1.3k citations

Joel Schlessinger's Hit Papers

Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa 2012 · 305 citations
3050+4+9Years since publication100200300

Peers

Joel Schlessinger
Comparison fields: 5 of 100
  • Dermatology 1.0k
  • Neurology 314
  • Immunology and Allergy 85
  • Surgery 477
  • Epidemiology 285
Replace Wolfgang G. Philipp‐Dormston with:
Wolfgang G. Philipp‐Dormston Germany
Moon Soo Yoon South Korea
Erick A. Mafong United States
Vasanop Vachiramon Thailand
Rungsima Wanitphakdeedecha Thailand
Arisa Ortiz United States
Rebecca Tung United States
J.H. Sillevis Smitt Netherlands
Miriam Weinstein Canada
Marina Landau Israel
Joel Schlessinger relative to Wolfgang G. Philipp‐Dormston Germany Wolfgang G. Philipp‐Dormston's profile →
Citations per field
00.5×3.4×
Wolfgang G. Philipp‐Dormston · 1×
Citations per year

Countries citing papers authored by Joel Schlessinger

Since Specialization
Citations

This map shows the geographic impact of Joel Schlessinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel Schlessinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel Schlessinger more than expected).

Fields of papers citing papers by Joel Schlessinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joel Schlessinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel Schlessinger. The network helps show where Joel Schlessinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Joel Schlessinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joel Schlessinger Line = papers co-authored together Joel Schlessinger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa
Hit paper breakdown →
2012305
2
Comparison of anti-inflammatory dose doxycycline versus doxycycline 100 mg in the treatment of rosacea.
200873
3 202066
4 201158
5
A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne.
200957
6
The efficacy and safety of a new U.S. Botulinum toxin type A in the retreatment of glabellar lines following open-label treatment.
200954
7 201748
8 201947
9 201145
10 201344
11
Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris.
200742
12 201237
13
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa:A parallel randomized trial
201236
14
A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.
200732
15 201228
16
Perceptions and practices in submental fat treatment: a survey of physicians and patients.
201327
17 201126
18 200625
19 200925
20 201825

About Joel Schlessinger

Joel Schlessinger is a scholar working on Dermatology, Neurology, Physiology, Surgery and Oncology, having authored 54 papers that have together received 1.4k indexed citations. Recurring topics across this work include Botulinum Toxin and Related Neurological Disorders (15 papers), Dermatologic Treatments and Research (14 papers), Dermatology and Skin Diseases (9 papers), Acne and Rosacea Treatments and Effects (8 papers), Cancer Treatment and Pharmacology (7 papers), Body Contouring and Surgery (7 papers), Facial Rejuvenation and Surgery Techniques (6 papers) and Pain Mechanisms and Treatments (6 papers). The work is most often cited by research in Dermatology (1.0k citations), Neurology (314 citations), Immunology and Allergy (85 citations), Surgery (477 citations) and Epidemiology (285 citations). Joel Schlessinger has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Philip Werschler, Joel L. Cohen, Alexa B. Kimball, Francisco A. Kerdel, Hessel H. van der Zee, Gregor B. E. Jemec, Joel M. Gelfand, Parvez Mulani, Robert Gniadecki and Ulrich Mrowietz. Their work appears in journals such as Dermatologic Surgery, Aesthetic Surgery Journal, Journal of Drugs in Dermatology, Journal of the American Academy of Dermatology and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact